Evidence map›Paper›PMID 21926562›Full record

ArticleAnesthesiology2011

Pharmacological consequence of the A118G μ opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca²⁺ channels in humanized mouse sensory neurons.

Saifeldin Mahmoud, Annika Thorsell, Wolfgang H Sommer, Markus Heilig, Joan K Holgate, Selena E Bartlett, Victor Ruiz-Velasco

Open access · bronzeAbstract read
In one paragraph

Article in Anesthesiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Molecular mechanism of allosteric modulation of opioid receptors.Signal transduction and targeted therapy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Neural Network Connectivity Following Opioid Dependence is Altered by a Common Genetic Variant in the µ-Opioid Receptor,The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  7. Article
  8. Review
  9. Genetic Vulnerability to Opioid Addiction.Cold Spring Harbor perspectives in medicine · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Update on the pharmacogenomics of pain management.Pharmacogenomics and personalized medicine · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Saifeldin MahmoudDepartment of Anesthesiology, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Annika Thorsell
Wolfgang H Sommer
Markus Heilig
Joan K Holgate
Selena E Bartlett
Victor Ruiz-Velasco
Ernest Gallo Clinic and Research Center · USNational Institute on Alcohol Abuse and Alcoholism · USHeidelberg University · DEPenn State Milton S. Hershey Medical Center · USWilliam Penn University · US

Funding

Excitability of Afferents Evoking the Exercise Pressor ReflexR01AR059397 · NIAMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI ELMSLIE, KEITH S, KAUFMAN, MARC PETER · 2010 to 2019
$5.4M
NIAMS NIH HHS AR-059397NIAMS NIH HHS R01 AR059397
6 · The paper itself

Abstract

backgroundThe most common functional single nucleotide polymorphism of the human OPRM1 gene, A118G, has been shown to be associated with interindividual differences in opioid analgesic requirements, particularly with morphine, in patients with acute postoperative pain. The purpose of this study was to examine whether this polymorphism would modulate the morphine and fentanyl pharmacological profile of sensory neurons isolated from a humanized mouse model homozygous for either the 118A or 118G allele.

methodsThe coupling of wild-type and mutant μ opioid receptors to voltage-gated Ca channels after exposure to either ligand was examined by employing the whole cell variant of the patch-clamp technique in acutely dissociated trigeminal ganglion neurons. Morphine-mediated antinociception was measured in mice carrying either the 118AA or 118GG allele.

resultsThe biophysical parameters (cell size, current density, and peak current amplitude potential) measured from both groups of sensory neurons were not significantly different. In 118GG neurons, morphine was approximately fivefold less potent and 26% less efficacious than that observed in 118AA neurons. On the other hand, the potency and efficacy of fentanyl were similar for both groups of neurons. Morphine-mediated analgesia in 118GG mice was significantly reduced compared with the 118AA mice.

conclusionsThis study provides evidence to suggest that the diminished clinical effect observed with morphine in 118G carriers results from an alteration of the receptor's pharmacology in sensory neurons. In addition, the impaired analgesic response with morphine may explain why carriers of this receptor variant have an increased susceptibility to become addicted to opioids.

Indexed as

Polymorphism, Single NucleotideAnalgesics, OpioidAnimalsCalcium ChannelsCells, CulturedDose-Response Relationship, DrugFemaleFentanylHumansMaleMiceMice, Inbred C57BLMorphineReceptors, Opioid, muSensory Receptor CellsTrigeminal GanglionAnalgesics, OpioidCalcium ChannelsFentanylMorphineReceptors, Opioid, mu

Identifiers

PMID21926562
PMCPMC3203255
OpenAlexW2116452148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.